Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azarga Add-on to Prostaglandin Monotherapy in Glaucoma
NCT00966576Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of brinzolamide in ocular hypertension, primary open-angle glaucoma (POAG) and pigmentary glaucoma (PG), sponsored by Alcon Inc. Primary endpoint: Mean decrease in intraocular pressure (IOP) from baseline at 12 weeks. Started Jul 2009; status: completed.
02
Drugs
brinzolamide
03
Conditions
ocular hypertensionprimary open-angle glaucoma (POAG)pigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT00966576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966576.